The impact of asymptomatic infections the Italian municipality of Vo' as a case study /

Hämta fulltext
Series

The immune system response to the SARS-CoV-2 virus March 2021 update /

Hämta fulltext
Series

Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state

Hämta fulltext
Series

The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells

Hämta fulltext
Series

Impact of COVID-19 on neuropsychiatric disorder and mental health

Hämta fulltext
Series

ABO blood groups and SARS-CoV-2 susceptibility

Hämta fulltext
Series

The COVID-19 outbreak April 2021 update /

Hämta fulltext
Series

Genetic surveillance and the emergence of SARS-CoV-2 variants

Hämta fulltext
Series

Identifying SARS-CoV-2 proteases

Hämta fulltext
Series

SARS-CoV-2 evolution within and between individuals

Hämta fulltext
Series

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Hämta fulltext
Series

SARS-COV-2 human monoclonal antibody therapy update

Hämta fulltext
Series

SARS-CoV-2 evolution emergence of the "Californian" and "Indian" variants /

Hämta fulltext
Series

SARS-CoV-2 variants implications for immunity and vaccine development /

Hämta fulltext
Series

mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals

Hämta fulltext
Series

SARS-CoV-2 monoclonal antibody testing in vivo

Hämta fulltext
Series

Potential of "long-COVID" in triggering chronic co-pathologies

Hämta fulltext
Series

Comparison of immune resilience induced by vaccination versus COVID recovery

Hämta fulltext
Series

The emergence of the SARS-CoV-2 Omicron variant

Hämta fulltext
Series

Artificial intelligence in precision medicine

Hämta fulltext
Series